ABSTRACT. I n vivo substrate utilization has not been described for the maturing fetal lung. We, therefore, studied pulmonary delivery and use of major fetal substrates in six chronically catheterized fetal lambs over 119-141 days gestation. Oxygen, glucose, lactate, and a-amino nitrogen concentrations were measured in the pulmonary artery and pulmonary vein whereas lung blood flow was determined using labeled microspheres. We found that lung oxygen availability and use increased near term. 
Using the chronically catheterized fetal sheep model (6), we determined the availability of major fetal substrates to the developing lung and lung substrate utilization during the third trimester. Pulmonary delivery and uptake of oxygen, glucose, lactate, and a-amino nitrogen were followed over the last weeks of gestation, allowing us to define the changing pattern of pulmonary substrate availability and use that accompanies advancing gestation.
METHODS
Surgical preparation and recovery. Six mixed Western, breeddated, pregnant sheep of 1 15-125 days gestation were surgically prepared with indwelling catheters, using methods described previously (6) . Six fetal lambs were catheterized, five singletons and one from a set of twins. Surgery was performed after the animals had fasted 24 h. Spinal anesthesia was induced with 2.0 ml of 1 % tetracaine hydrochloride and analgesia was provided with intravenous pentobarbital (65 mg/ml) as needed. Polyvinyl catheters (0.050 inch inner diameter and 0.090 inch outer diameter) were placed in the maternal femoral artery and vein. The uterus was then exposed through a midline abdominal incision and opened. Local anesthesia with 1% xylocaine was used for all fetal incisions; pentobarbital (5-10 mg/kg) and succinyl choline (1 mg/kg) were given as needed for fetal sedation and to minimize fetal movement. Catheters (0.030 inch inner diameter and 0.048 inch outer diameter) were inserted either into the fetal femoral artery and vein of one hindlimb (four animals) or into the carotid artery and jugular vein (two animals). The fetal chest was then exposed and a thoracic incision was made on the left side, from sternum to spine. The pleural space was entered through the fourth intercostal space and the lungs were gently retracted. The pericardium was opened and a 20-gauge Teflon catheter, fitted on a piece of polyvinyl tubing (7), was then placed into the main pulmonary artery. A catheter (0.01 1 inch inner diameter and 0.030 inch outer diameter) was inserted into a distal pulmonary vein and threaded up into a major vein draining the upper lobe of the left fetal lung. The fetal chest was then closed. A multipore amniotic fluid catheter was anchored in the uterus and the uterus was also sutured closed. All catheters were exteriorized through a stab wound in the maternal flank, where they were protected by a mesh pocket. At surgery, penicillin (1 million units) and kanamycin (200 mg) were given to the ewe intravenously and were also instilled into the amniotic cavity.
After surgery the ewes were fed ad libitum on alfalfa meal and water. They were accustomed to our laboratory environment by daily handling. Antibiotic administration, as described above, was repeated for 5 days after surgery and all catheters were flushed with heparin (1000 U/ml) daily.
Study protocol. After the initial recovery period, each animal was repetitively studied for pulmonary uptake of major substrates and pulmonary blood flow. Studies were carried out in the midday with the mothers in familiar movable pens. All studies reported herein were performed between 119 and 141 days gestation, at least 4 days after surgery, and at least 2 days before spontaneous delivery or fetal demise. All ewes and fetuses were in good health with fetal femoral or carotid arterial pH > 7.30.
At study, fetal blood samples were drawn simultaneously from the fetal pulmonary artery and pulmonary vein. Analyses were carried out for whole blood concentrations of glucose, lactate, total amino acids (measured as a-amino nitrogen), Hb, oxygen saturation, pH, and Pa02. Two complete sets of metabolite and blood gas measurements were made and averaged to obtain a study value. The substrate and blood gas measurements were repeated one to two times weekly. Fetal pulmonary blood flow was measured with radiolabeled microspheres at the time of substrate sampling. Flow measurements were made in duplicate and averaged to obtain a study value.
A blood sample was also drawn from the maternal artery during each study. This was used to measure maternal metabolite levels and blood gases.
Repetitive studies in these animals spanned an average period of 14 + 2 (SEM) days. Mean gestational age at delivery or death was 140 k 2 days. At delivery fetal weight was obtained, and the lungs were collected and weighed. Thereafter, the lungs were carbonized and counted for radioactivity to calculate lung blood flow. Average birth weight of the fetuses studied was 3746 k 46 1 g, total lung wet weight averaged 8 1 k 14 g, and the mean lung/ body weight ratio was 2.1 + 0.3%; all values were within the normal range (8) (9) (10) . The wet weights of the instrumented left upper lobes of the lung in study animals were 12 k 2 g, similar to the 13 k 2 g weight of left upper lobes in animals without pulmonary catheters in our laboratory.
Analytical methods. All metabolites were analyzed in whole blood, in duplicate. The deproteinization steps in the assays for glucose, lactate, and a-amino nitrogen were camed out with iced reagents, immediately after blood drawing. The supernatant obtained was frozen at -40" C. After delivery, samples from repetitive studies on the same animal were thawed and analyzed together in the same assay run. Glucose concentration was analyzed by an enzymatic, colorimetric glucose oxidase method, lactate by a lactate dehydrogenase assay (both assays from Sigma Chemical Co., St. Louis, MO), and a-amino nitrogen by a colorimetric method involving the combination of a-amino nitrogen groups on amino acids with b-napthoquinone sulfonate (1 1, 12) . Our mean percentage error between duplicate fetal samples was 1.8% for glucose, 1.5% for lactate, and 3.8% for aamino nitrogen. Blood gases were measured immediately after blood drawing, on a Coming 158 pH/blood gas analyzer (Coming Medical, Medford, MA). Hb concentration and oxgyen saturation were measured, in duplicate, on a Radiometer-Copenhagen OSM 2 hemoximeter (The London Co., Westlake, OH). Calibration of both machines was checked before each study. Our mean percentage error between duplicate measurements of Hb was 1 .O% and for oxygen saturation it was 0.8%.
Oxygen content was calculated using the formula (1 3):
The accuracy of this method for fetal blood has been verified (14) . Because of occasional laboratory error or difficulty with catheter sampling, blood samples were not always analyzed for every metabolite. Simultaneous PA-PV substrate differences also could not be obtained at the time of several lung blood flow measurements.
The percentage of pulmonary oxidative metabolism that could be accounted for by complete oxidation of glucose was calculated using the glucose to oxygen quotient. Inasmuch as 6 mol of moles oxygen are used during complete oxidative combustion of 1 mol of glucose to carbon dioxide and water, the ratio was calculated as:
The percentage of oxidative metabolism that could be accounted for by glucose oxidation, in the face of pulmonary lactate production from glucose, was calculated as the (glucose-lactate) to oxygen quotient. Because each mole of glucose produces 2 mol of lactate, this was calculated as:
glucose-lactate oxygen
Delivery of nutrients and oxygen to the lung was calculated as PA concentration times pulmonary blood flow. Uptake by the lung was calculated by multiplying the PA-PV concentration difference times pulmonary blood flow. For purposes of calculating substrate uptake, blood draining the left upper pulmonary lobe was assumed to be representative of blood draining the lung as a whole.
Blood flow to the lungs was measured using 15 pm in diameter radiolabeled microspheres (New England Nuclear, Boston, MA). The microspheres were injected into the fetal inferior vena cava (through the femoral vein) or into the superior vena cava (through the jugular vein), while a reference sample was simultaneously withdrawn from the PA at a constant rate. Blood flow was calculated using the following formula (6): pulmonary arterial blood flow (ml/min) --radioisotope counts in lungs radioisotope counts in reference sample
x PA reference sample flow (ml/min)
Most of the microspheres injected into the IVC will reach the fetal lungs through the pulmonary artery. Because a small number of IVC-injected spheres will also reach the lungs through the bronchial circulation, we determined whether omission of bronchial flow would have a measurable effect on our calculation of lung blood flow and substrate uptake. During six studies in two animals, microspheres carrying a different radiolabel were injected through the PV, while pulmonary arterial blood flow measurements were made. A second reference sample was simultaneously drawn from the FA. Microspheres injected into the PV will pass into the left side of the heart and then into the aortic arch and descending aorta. They will reach the lungs only through the bronchial arteries; these come off the bronchoesophageal trunk from the descending aorta in the sheep (15) . Using lung counts of the PV-injected radiolabeled spheres and the FA reference sample, bronchial flow was calculated as described for pulmonary flow above. Then, using the bronchial flow and the concentration of IVC-injected labeled spheres in the FA reference sample, we could determine the quantity of IVC-injected microspheres reaching the lungs through the bronchial circulation. After subtracting the bronchially derived spheres from the lung isotope counts of IVC injected spheres, corrected calculation of actual pulmonary blood flow was made. Total lung blood flow was determined as corrected pulmonary flow + bronchial flow.
Bronchial flow was found to average 14 f 3% (n = 6) of total lung flow. Measurements of total lung flow differed from uncorrected pulmonary blood flow measurements by only 5 k 1 % (n = 6). This was because the overestimate of pulmonary flow in uncorrected measurements was essentially equal to bronchial flow. Nonsignificant differences of 6 + 1% were found between substrate uptakes calculated as either (PA-PV substrate difference x corrected PA flow) + (FA-PV substrate difference x bronchial flow) versus uptake calculated as (PA-PV substrate difference x uncorrected pulmonary blood flow). The latter calculation was, therefore, used for all studies presented herein.
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Comparisons within the same animals, with respect to changes in substrate levels over time and PA-PV substrate differences were made using the paired t test (16) . The unpaired t test was used when comparisons were made using data from different animals (1 6) . Relationships between gestational age and substrate metabolism and between the different substrates was defined using the correlation coefficient and regression analysis, by the least squares method (16) . A p value of 50.05 was accepted as demonstrating a significant difference or correlation.
RESULTS
Over the 3-wk study period (1 19-14 1 days gestation) , pulmonary blood flow was found to increase as gestation advanced (r = 0.40, n = 25, p < 0.05). Measurements of pulmonary blood flow made over the first week of this period ( 5 127 days gestation) was 64 f 12 ml/min (n = 7), which was significantly different from the average flow of 110 + 15 ml/min (n = 9) measured during the last week in maturing fetuses ( r 134 days) ( p < 0.05).
In pulmonary arterial blood perfusing the fetal lung, the PaOl averaged 19.3 + 3.7 mm Hg, the mean PaOz saturation was 4 1.3 f 1.5%, Hb content was 9.5 + 0.3 g/ll, and PA oxygen content was 5.25 +. 0.19 ml/dl (for all n = 36). There was no change in PA Pa02, oxygen saturation, or oxygen content with gestational age, but Hb concentration did increase with fetal gestation (r = 0.34, n = 36, p < 0.05).
Delivery of oxygen to the lungs averaged 4.96 f 0.48 ml/min (n = 25) and increased with gestation ( Fig. 1) . In observations made during the last week (2 134 days), oxygen delivery averaged 6.15 f 0.76 ml/min (n = 9), compared to 4.29 + 0.54 ml/min (n = 16) for observations made at younger gestations (<I34 days) ( p < 0.05).
Oxygen uptake was documented across the pulmonary circulation in 24 of 25 paired PA-PV differences; one difference was zero. The mean PA-PV oxygen content difference was 8 18 + 90 plldl (n = 25, p < 0.001) and this did not change as the fetus matured. For those measurements where simultaneous blood flow was available, oxygen uptake averaged 708 f 1 I I pl/min (n = 15) or 17 + 2% (n = 15) of pulmonary oxygen delivery.
Oxygen uptake correlated significantly with oxygen delivery to the lungs (Fig. 2) and increased with gestation. Oxygen uptake averaged 494 f 104 pllmin (n = 8) in observations made at <I34 days gestation compared to 952 + 168 pl/min (n = 7) for observations made at r 134 days ( p < 0.05).
The average concentration of glucose in the PA over the study period was 19.42 f 0.90 mg/dl (n = 36). Interestingly, the During the weeks of study, delivery of glucose to the fetal lung averaged 16.56 1.73 mglmin (n = 25). Glucose delivery did not change with gestation because the decrease in glucose concentration was balanced by the increase in pulmonary flow.
Glucose was found to be taken up by the fetal lung in large amounts. Glucose content was higher in the PA compared to the PV in 24 of 26 samples, with a mean glucose difference of 1.3 1 + 0.20 mg/dl (n = 26, p < 0.001). This difference tended to decrease with advancing gestation (n = 26, r = 0.38, p < 0.1).
For those observations where blood flow was available, pulmonary glucose uptake averaged 844 f 225 pg/dl (n = 15) and equaled 8 + 1 % (n = 15) of glucose delivery. Of note was the fact that lung glucose uptake decreased as the fetus approached term; this relationship is graphed in Figure 4 .
The average concentration of lactate in the PA was 15.04 f 0.42 mgldl (n = 36) which did not change as the fetus matured. Lactate delivery to the lung averaged 13.8 It-1.5 mg/min (n = 25) and also did not change with gestation.
In contrast to pulmonary uptake of glucose, lactate was produced by the lung. The PA-PV difference in lactate was positive in 25 of 26 samples. The mean PV-PA difference was 787 + 16 pgldl (n = 26, p < 0.001), and in observations where blood flow was measured, production of lactate averaged 534 + 176 pglmin (n = 15). Neither the PV-PA difference nor lactate production changed over time. Where glucose uptake across the lung was simultaneously documented, lactate production would have accounted for 50 f 16% of glucose uptake (n = 13), assuming that lactate was derived from glucose.
The average PA a-amino nitrogen was 8.81 +-0.22 mgldl (n = 36) and amino nitrogen was noted to increase with gestation. PA a-amino nitrogen in observations made at <I34 days was 8.32 f 0.21 mgldl (n = 23), compared to 9.67 +-0.39 mgldl (n during the weeks of study and increased significantly as gestation advanced (Fig. 5) . PA a-amino nitrogen delivery before 134 days During the last week of study, seven of 10 G/Oz ratios were (1.0 and over the last 4 days the G/02 averaged 0.58 (n = 4). When lactate production was subtracted from glucose uptake, the resultant G-L/02 ratio was found to average 0.67 + 0.26 (n = 24). There was no correlation between gestational age and G-L/Oz.
DISCUSSION
The aims of this study were to identify the major substrates used by the lung during the last trimester of gestation and to define the metabolic changes that occur in the maturing lung in vivo. Our results indicate that the fetal lung is metabolically active, using oxygen and glucose and producing lactate. Pulmonary substrate availability and utilization are not static and change with advancing gestation. Observations made in fetuses of 134 days or more showed significant differences in lung metabolism compared to younger animals. This is of interest because maturation of the lung in the sheep occurs at 134 to 135 days gestation as indicated by increased surfactant availability, disappearance of lung glycogen, and increase in lung distensibility (17) (18) (19) (20) (21) .
In the third trimester fetal lamb, the lung consumed 708 & 1 1 1 j~g/min of oxygen, or approximately 4% of the total quantity of oxygen taken up across the placenta (8) . The average oxygen uptake at and after 134 days gestation was 93% more than the average oxygen uptake found in younger fetuses of 120 to 134 days gestation. Oxygen delivery also increased 43% over the same period, with oxygen uptake closely correlated with delivery. Over the gestational period studied, lung weight increases only 24% (10,22; Simmons RA, Charlton VE, personal observations). Oxygen delivery and utilization are, therefore, increasing more rapidly than lung size, resulting in an actual increase in oxygen availability and utilization per unit weight of fetal lung near term.
Glucose was found to be a major oxidative substrate in the lung, as has been reported for the total fetus and individual organs (1, 2, 5, 23). However, unlike oxygen, availability of SIMMONS AND CHARLTON glucose to the lungs decreased as the fetus matured. Pulmonary arterial glucose concentration fell over the period of study. Measurements made at 2 134 days gestation averaged 18 % lower than those made in younger fetuses and a decrease of 28% was found between initial and final studies in individual animals. The decline in glucose concentration was similar to, but of greater magnitude than, those previously found in femoral artery samples from fetal sheep over the last weeks of gestation (8, 9) .
Glucose delivery to the lungs remained static over the final weeks of the third trimester; the decrease in pulmonary artery glucose was balanced by an increase in pulmonary blood flow. However, because lung size was increasing, glucose delivery per unit of lung weight actually declined during this period. The average glucose uptake by the lung was 844 + 225 ~g/min, or 5% of the total glucose taken up across the placenta (8) , but concomitant with the decline in glucose availability near term, utilization of glucose fell. Inasmuch as pulmonary oxygen delivery and oxidative metabolism were found to be increasing over the period, the decrease in pulmonary glucose use noted was not due to any deterioration of our fetal preparations. Furthermore, the fall in fetal pulmonary glucose concentration was not due to any change in maternal glucose levels, which were stable during the study period. We suggest that the observed decrease in glucose concentration and availability per unit of lung weight may serve as a physiologic signal, which leads to metabolic changes in the lung that are part of the normal maturational process. In situations where glucose delivery to the lung remains high near term, metabolic maturation of the fetal lung may be compromised. This is supported by the observation that fetal hyperglycemia is implicated as a major etiologic factor in the pathogenesis of the respiratory distress syndrome (leading to decreased surfactant availability) in the infants of diabetic mothers (24, 25) . Further, in vitro studies have described a much greater lung utilization of glucose in fetal animals than in newborn and older animals (26) .
The fetus as a whole is known to be a net consumer of lactate, because there is fetal uptake of lactate from the placenta via the umbilical circulation (27) . However, lactate is also produced within the fetus at high rates (28) . Our study demonstrates that the fetal lung is one of the organs that normally produce lactate. Conversion of glucose to lactate has been demonstrated by radiolabeled glucose infusions in the sheep (28, 29) and in type I1 fetal pneumocytes in vitro (30) . Most likely fetal pulmonary lactate is being derived from glucose and the high rate of lactate production would account for 50% of pulmonary glucose uptake. Our in vivo findings in the sheep are in agreement with in vitro studies verformed on isolated fetal tvve I1 vneumocvtes. High rates ofiactate production were also found in the fetai pneum%-cytes, with lactate synthesis accounting for 79% of cellular glucose utilization (30) .
Although the fetus as a whole uses and catabolizes amino acids (3 1, 32), we could not detect a significant uptake of total amino acids (measured as amino nitrogen) across the lung. However, the quantity of amino acids reaching the lung increased significantly as gestation advanced. The concentration of total amino acids in the pulmonary artery increased by 16% in fetuses 2134 days compared to younger animals. Similar percentage increases in femoral arterial amino acid concentration have been previously noted in the fetal lamb close to term (8, 9) . With the increase in pulmonary blood flow, amino acid delivery to the lung was 48% more during the last week of gestation than earlier.
Inasmuch as amino acid delivery increased more rapidly than lung weight, availability of total amino acids per unit lung weight rose. Whether increased total amino acid availability is necessary for the developing lung is unclear. It is possible that amino acids serve as signals for as yet unidentified structural changes or for lung growth (22) . We were unable to demonstrate pulmonary utilization of total amino acids, but uptake of small quantities of amino acids for protein synthesis or oxidative catabolism would have been missed by our methods. Further, changes in delivery or uptake of specific amino acids were not evaluated.
A substrate to oxygen quotient is an expression of the proportion of total oxygen uptake that can be accounted for if a substrate is completely oxidized to carbon dioxide and water. The umbilical G/02 ratio in the fetal sheep has been reported as 0.41 to 0.57 (8, 33) . This indicates that the amount of glucose taken up by the total fetus is less than the amount of substrate needed to sustain fetal energy metabolism and other metabolites such as amino acids and lactate are also used to fuel oxidative metabolism (27, 31) . However, several individual fetal organs take up large quantities of glucose, which totally account for or even exceed their fuel needs for oxidative metabolism. Examples are the hindlimb (G/02 of 1.2) and the brain (G/02 of 1 .O) (4, 34) .
We found that the G/Oz in the fetal lung averaged 1.48, indicating that if all the glucose taken up by the lung were oxidized to carbon dioxide and water, glucose uptake would more than account for pulmonary oxygen consumption. As gestation advanced, however, this ratio fell to less than one, indicating that near term complete oxidation of glucose could not account for lung oxidative metabolism. Further, a large fraction of the glucose taken up throughout the third trimester is probably not being oxidized because the lung is also producing a large amount of lactate. Corrected for lactate production, the pulmonary G-L/02 ratio was approximately 0.70. This implies that more than 30% of fetal pulmonary oxidative metabolism still remains unidentified. Other possible substrates need to be investigated.
In summary, the fetal lung consumes large amounts of glucose relative to its oxygen consumption and produces lactate. However, more than 30% of the substrate burned oxidatively by the lung is unidentified. There are significant differences in lung metabolism as gestation progresses. Pulmonary oxygen delivery and uptake increase, glucose availability and uptake decrease, and amino acid availability increases. These changes in substrate availability may serve as signals for maturation of the fetal lung, with the increase in oxidative metabolism and decrease in glucose utilization indicative of the metabolic changes accompanying maturation.
